Cargando…
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
Glioblastoma multiforme (GBM) is the most common primary brain tumor and among the most difficult to treat malignancies per se. In almost 90% of all GBM alterations in the PI3K/Akt/mTOR have been found, making this survival cascade a promising therapeutic target, particular for combination therapy t...
Autores principales: | Ströbele, Stephanie, Schneider, Matthias, Schneele, Lukas, Siegelin, Markus D., Nonnenmacher, Lisa, Zhou, Shaoxia, Karpel-Massle, Georg, Westhoff, Mike-Andrew, Halatsch, Marc-Eric, Debatin, Klaus-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488267/ https://www.ncbi.nlm.nih.gov/pubmed/26121251 http://dx.doi.org/10.1371/journal.pone.0131670 |
Ejemplares similares
-
The effects of PI3K-mediated signalling on glioblastoma cell behaviour
por: Langhans, Julia, et al.
Publicado: (2017) -
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells
por: Hasslacher, Sebastian, et al.
Publicado: (2018) -
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014) -
A potential role of PI3K inhibition in radiotherapy of glioblastoma multiforme
por: Langhans, Julia, et al.
Publicado: (2015) -
The limitations of targeting MEK signalling in Glioblastoma therapy
por: Selvasaravanan, Karthika D., et al.
Publicado: (2020)